4.7 Article

Randomized controlled phase III trial of adjuvant chemoimmunotherapy with activated cytotoxic T cells and dendritic cells from regional lymph nodes of patients with lung cancer

Related references

Note: Only part of the references are listed.
Article Oncology

Molecularly Targeted Therapies in Non-Small-Cell Lung Cancer Annual Update 2014

Daniel Morgensztern et al.

JOURNAL OF THORACIC ONCOLOGY (2015)

Review Oncology

Circulating tumor cells as therapy-related biomarkers in cancer patients

Tobias M. Gorges et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)

Review Oncology

Immune-suppressive properties of the tumor microenvironment

Juergen C. Becker et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)

Review Oncology

Cellular Constituents of Immune Escape within the Tumor Microenvironment

Sid P. Kerkar et al.

CANCER RESEARCH (2012)

Article Medicine, General & Internal

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

Marco Gerlinger et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Review Oncology

Intra-tumour heterogeneity: a looking glass for cancer?

Andriy Marusyk et al.

NATURE REVIEWS CANCER (2012)

Review Multidisciplinary Sciences

Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion

Robert D. Schreiber et al.

SCIENCE (2011)

Review Biochemistry & Molecular Biology

The tumor microenvironment and its role in promoting tumor growth

T. L. Whiteside

ONCOGENE (2008)

Review Immunology

Cancer immunoediting from immune surveillance to immune escape

Ryungsa Kim et al.

IMMUNOLOGY (2007)

Article Medicine, General & Internal

Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer

T Le Chevalier et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

Review Immunology

Cancer immunoediting: from immunosurveillance to tumor escape

GP Dunn et al.

NATURE IMMUNOLOGY (2002)